ITGB1 expression was observed in 42.9% (21/49) of T1‐stage cancers, 63.0% (34/54) of T2‐stage cancers, and 64.0% (203/317) of T3 + T4‐stage cancers (Figure 2A). Here, ITGB1 is linked to cancer.